Market revenue in 2024 | USD 8.0 million |
Market revenue in 2030 | USD 15.5 million |
Growth rate | 11.7% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Obsessive Compulsive Disorder (OCD) |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dystonia was the largest segment with a revenue share of 81.25% in 2024. Horizon Databook has segmented the Malaysia deep brain stimulation devices market based on pain management, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
Malaysia, being a developing country, began its movement disorder program for PD affected patients by undertaking ablation therapy using radionics system (electromagnetic therapy). Furthermore, after the increase in awareness among individuals and healthcare professionals, long-term benefits of deep brain stimulation was evaluated.
Some of the companies operating in deep brain stimulation segment are Medtronic and Boston Scientific Medical Device. Thus, presence of companies and increase in awareness programs are expected to drive the growth of deep brain stimulation devices market in Malaysia.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account